Marks Believes Trump Team Will Not Threaten US FDA’s Medicines Expertise

The US FDA’s Peter Marks told the Jefferies meeting that scientific leadership will be protected and that the agency wants to do more to help the sector accelerate innovation.

CBER Director Peter Marks said he was not worried about rhetoric and that the FDA's high standards would be preserved. (Shutterstock)

More from Elections

More from Legislation